In part two of the three-part series on writing a strong commercialization plan, NCI SBIR Program Director William Bozza is joined by NCI SBIR-funded, Beatrice Langton-Webster, director and CEO of Cancer Targeted Technology, Madelyn Herzfeld, co-Founder and vice chairman of Carevive Systems, and Carlos Castro-Gonzalez, co-founder and CEO of Leuko Labs, who share insights on this key Phase II SBIR/STTR application component.

SBIR DEVELOPMENT CENTER SBIR Innovation Lab Podcast: https://sbir.cancer.gov/about/innovation-lab-podcast SBIR Development Center: https://sbir.cancer.gov/

LEARN MORE FROM THE NATIONAL CANCER INSTITUTE Online: https://www.cancer.gov By Phone: 1-800-4-CANCER (1-800-422-6237)

U.S. Department of Health and Human Services National Institutes of Health National Cancer Institute